Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Starlight who wrote (1261)	6/1/2000 7:00:00 PM
From: michaele23	Read Replies (1) \| Respond to of 1605

I think the main reason that the stock went up to 14, actually, was due to the release of the Mayo clinic news, backed up by the fundamentals of the company getting the Medicare approval, the increasing sales and the promise of EECP itself. This happened in a bull market which helped, of course. So it wasn't one thing, but the trigger was clearly the news from the Mayo Clinic getting out there. It sold off pretty quickly back down to about 8 or 9 I think. Now I see a higher price coming out of news that will be ongoing. It is better if the price builds more slowly because that means a stronger base of buyers who are holding, which is what is happening now. It wouldn't surprise me to see 20 before the end of this month if the market holds up, boosted along by news and increasing public and market awareness. I also think with all the increased revenue, probably at least a 20-25% increase over last quarter, that the price will hold up a lot better, even with a down market. Next year this company will fly.